Herb Integrative Database

Traditional Medicine Data Platform

Graph Explorer

Knowledge Graph

Explore multi-hop entity graphs, core paths, node details, and edge details.

Center Graph

2 hop / 30 nodes / 34 edges

Loading graph canvas

Initializing node layout and zoom controls.

Path Exploration

Herb -> Ingredient -> Target -> Disease

洋金花->(1r,2r,5r,6s)-2-[(8s,9s,10r,13s,14s,17r)-10,13-dimethyl-1-oxo-4,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-(methoxymethyl)-5-methyl-4,8-dioxabicyclo[3.3.1]nonan-7-one->AR->21-hydroxylase deficiency

Has IngredientTargetsAssociated With

Herb -> Ingredient -> Target -> Disease

洋金花->(1r,2r,5r,6s)-2-[(8s,9s,10r,13s,14s,17r)-10,13-dimethyl-1-oxo-4,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-(methoxymethyl)-5-methyl-4,8-dioxabicyclo[3.3.1]nonan-7-one->AR->46, XX Testicular Disorders of Sex Development

Has IngredientTargetsAssociated With

Herb -> Ingredient -> Target -> Disease

洋金花->(1r,2r,5r,6s)-2-[(8s,9s,10r,13s,14s,17r)-10,13-dimethyl-1-oxo-4,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-(methoxymethyl)-5-methyl-4,8-dioxabicyclo[3.3.1]nonan-7-one->AR->46, XY Disorders of Sex Development

Has IngredientTargetsAssociated With

Herb -> Ingredient -> Target -> Disease

洋金花->(1r,2r,5r,6s)-2-[(8s,9s,10r,13s,14s,17r)-10,13-dimethyl-1-oxo-4,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-(methoxymethyl)-5-methyl-4,8-dioxabicyclo[3.3.1]nonan-7-one->AR->46, XY female

Has IngredientTargetsAssociated With

Herb -> Ingredient -> Target -> Disease

洋金花->(1r,2r,5r,6s)-2-[(8s,9s,10r,13s,14s,17r)-10,13-dimethyl-1-oxo-4,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-(methoxymethyl)-5-methyl-4,8-dioxabicyclo[3.3.1]nonan-7-one->AR->5-Alpha Reductase Deficiency

Has IngredientTargetsAssociated With

Herb -> Ingredient -> Target -> Disease

洋金花->(1r,2r,5r,6s)-2-[(8s,9s,10r,13s,14s,17r)-10,13-dimethyl-1-oxo-4,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-6-(methoxymethyl)-5-methyl-4,8-dioxabicyclo[3.3.1]nonan-7-one->AR->Abnormal Behavior

Has IngredientTargetsAssociated With